KIM AUSTIN D. 4
4 · ACADIA PHARMACEUTICALS INC · Filed Feb 27, 2023
Insider Transaction Report
Form 4
KIM AUSTIN D.
EVP AND GENERAL COUNSEL
Transactions
- Exercise/Conversion
Common Stock
2023-02-23+2,214→ 20,911 total - Exercise/Conversion
Restricted Stock Units
2023-02-23−2,214→ 4,428 total→ Common Stock (2,214 underlying) - Sale
Common Stock
2023-02-24$18.78/sh−803$15,080→ 20,108 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units.
- [F3]The restricted stock units vest in four equal annual installments beginning February 23, 2022.